肺立体定向消融放疗靶区实际交付剂量与计划剂量的对比分析
本研究回顾性分析72例非小细胞肺癌患者接受60 Gy/4次立体定向消融放疗的记录,基于每次分次生成的288个自适应CT评估实际交付剂量。结果显示处方剂量准确交付至内靶区,但部分病例的PTV交付剂量与计划存在差异,且该差异与形变配准参数及均匀性指数变化相关。
要点
- 处方剂量准确交付至内靶区,最大差异在1%以内。
- 超过95%的自适应CT病例中,PTV计划与交付剂量差异在6%以内。
- 高ΔHI病例的PTV D95%较低,与形变配准的Warpmean和DSC较高相关。
核心结论
- 基于自适应CT评估显示,SABR处方剂量准确交付至内靶区,但部分PTV病例因均匀性指数偏离原计划而出现交付剂量变化,可能与治疗时患者摆位等因素有关。
研究设计与样本
- 回顾性研究分析72例非小细胞肺癌患者的SABR治疗记录,处方剂量为60 Gy分4次至PTV 95%体积。
- 通过刚性和形变配准将计划CT与每次分次的锥形束CT配准,共生成288个自适应CT用于剂量计算。
- 每个自适应CT作为独立计划CT输入治疗计划系统计算剂量,患者交付剂量由4次分次的自适应CT计算剂量平均得到。
- 采用多元线性回归和单因素方差分析(SPSS版本27)分析几何与剂量学参数。
主要发现
- 处方剂量确认完全交付至内靶区,最大差异为1%。
- 超过95%的自适应CT病例中,PTV计划与交付剂量差异在6%以内。
- 治疗过程中内靶区体积变化较小,与其标准差相比差异不大。
- 多元线性回归显示Warpmean、DSC、计划CT与自适应CT间的ΔHI、Dmean四个PTV参数与PTV D95%显著相关(P值<0.05)。
- 高ΔHI的自适应CT病例由形变图像配准的Warpmean和DSC较高值引起,导致PTV D95%交付较低;PTV D95%和Warpmean均值因肿瘤所在肺叶不同而存在显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adaptive therapy has been enormously improved based on the art of generating adaptive computed tomography (ACT) from planning CT (PCT) and the on-board image used for the patient setup. Exploiting the ACT, this study evaluated the dose delivered to patients with non-small-cell lung cancer (NSCLC) patients treated with stereotactic ablative radiotherapy (SABR) and derived relationship between the delivered dose and the parameters obtained through the evaluation procedure. METHODS: SABR treatment records of 72 patients with NSCLC who were prescribed a dose of 60 Gy (Dprescribed) to the 95% volume of the planning target volume (PTV) in four fractions were analysed in this retrospective study; 288 ACTs were generated by rigid and deformable registration of a PCT to a cone-beam computed tomography (CBCT) per fraction. Each ACT was sent to the treatment planning system (TPS) and treated as an individual PCT to calculate the dose. Delivered dose to a patient was estimated by averaging four doses calculated from four ACTs per treatment. Through the process, each ACT provided the geometric parameters, such as mean displacement of the deformed PTV voxels (Warpmean) and Dice similarity coefficient (DSC) from deformation vector field, and dosimetric parameters, e.g. difference of homogeneity index (ΔHI, HI defined as (D2%-D98%)/Dprescribed*100) and mean delivered dose to the PTV (Dmean), obtained from the dose statistics in the TPS. Those parameters were analyzed using multiple linear regression and one-way-ANOVA of SPSS® (version 27). RESULTS: The prescribed dose was confirmed to be fully delivered to internal target volume (ITV) within maximum difference of 1%, and the difference between the planned and delivered doses to the PTV was agreed within 6% for more than 95% of the ACT cases. Volume changes of the ITV during the treatment course were observed to be minor in comparison of their standard deviations. Multiple linear regression analysis between the obtained parameters and the dose delivered to 95% volume of the PTV (D95%) revealed four PTV parameters [Warpmean, DSC, ΔHI between the PCT and ACT, Dmean] and the PTV D95% to be significantly related with P-values < 0.05. The ACT cases of high ΔHI were caused by higher values of the Warpmean and DSC from the deformable image registration, resulting in lower PTV D95% delivered. The mean values of PTV D95% and Warpmean showed significant differences depending on the lung lobe where the tumour was located. CONCLUSIONS: Evaluation of the dose delivered to patients with NSCLC treated with SABR using ACTs confirmed that the prescribed dose was accurately delivered to the ITV. However, for the PTV, certain ACT cases characterised by high HI deviations from the original plan demonstrated variations in the delivered dose. These variations may potentially arise from factors such as patient setup during treatment, as suggested by the statistical analyses of the parameters obtained from the dose evaluation process.
引用
- Yu GB, Kim JI, Kim HJ, et al. Comparative analysis of delivered and planned doses in target volumes for lung stereotactic ablative radiotherapy. Radiat Oncol. 2024. PMID: 39152502. doi:10.1186/s13014-024-02505-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。